000			01973 a2200577 4500
005			20250516154755.0
264		0	_c20140113
008			201401s 0 0 eng d
022			_a1930-739X
024	7		_a10.1002/oby.20081 _2doi
040			_aNLM _beng _cNLM
100	1		_aHe, J
245	0	0	_aCardiometabolic risks during anabolic hormone supplementation in older men. _h[electronic resource]
260			_bObesity (Silver Spring, Md.) _cMay 2013
300			_a968-75 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdiponectin _xblood
650	0	4	_aAdipose Tissue _xmetabolism
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAging
650	0	4	_aAnabolic Agents _xadverse effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBody Composition _xdrug effects
650	0	4	_aBody Fluid Compartments _xmetabolism
650	0	4	_aBody Mass Index
650	0	4	_aCardiovascular Diseases _xetiology
650	0	4	_aCholesterol, HDL _xblood
650	0	4	_aDietary Supplements _xadverse effects
650	0	4	_aDouble-Blind Method
650	0	4	_aHormone Replacement Therapy _xadverse effects
650	0	4	_aHuman Growth Hormone _xadverse effects
650	0	4	_aHumans
650	0	4	_aInsulin Resistance
650	0	4	_aMale
650	0	4	_aMultivariate Analysis
650	0	4	_aRisk Factors
650	0	4	_aTestosterone _xadverse effects
650	0	4	_aTriglycerides _xblood
700	1		_aBhasin, S
700	1		_aBinder, E F
700	1		_aYarasheski, K E
700	1		_aCastaneda-Sceppa, C
700	1		_aSchroeder, E T
700	1		_aRoubenoff, R
700	1		_aChou, C-P
700	1		_aAzen, S P
700	1		_aSattler, F R
773	0		_tObesity (Silver Spring, Md.) _gvol. 21 _gno. 5 _gp. 968-75
856	4	0	_uhttps://doi.org/10.1002/oby.20081 _zAvailable from publisher's website
999			_c22851248 _d22851248